resveratrol has been researched along with amphotericin b in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
da Silva, CJ; de Fátima, Â; de Paiva Silva, S; Derita, M; Fernandes, SA; Liberto, NA; Modolo, LV; Romanelli, GP; Silva, LM; Simões, JB; Zacchino, S; Zuñiga, OMP | 1 |
Ferreira, C; Nascimento, MT; Pinto-da-Silva, LH; Saraiva, EM; Sarzedas, CG; Soares, DC; Tinoco, LW | 1 |
Bauab, TM; Bernegossi, J; Bonifácio, BV; Chorilli, M; de Toledo, LG; Miyashiro, CA; Ramos, MAS | 1 |
4 other study(ies) available for resveratrol and amphotericin b
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Quinolines: Microwave-assisted synthesis and their antifungal, anticancer and radical scavenger properties.
Topics: Antifungal Agents; Candida albicans; Cell Line; Cell Proliferation; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Free Radical Scavengers; Humans; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Quinolines; Structure-Activity Relationship | 2017 |
Resveratrol is active against Leishmania amazonensis: in vitro effect of its association with Amphotericin B.
Topics: Amphotericin B; Antiprotozoal Agents; Computational Biology; Drug Synergism; Leishmania; Magnetic Resonance Spectroscopy; Resveratrol; Ristocetin; Stilbenes | 2014 |
Development and characterization of a novel liquid crystalline system containing sodium alginate for incorporation of
Topics: Alginates; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Delivery Systems; Emulsions; Fluconazole; Hydrophobic and Hydrophilic Interactions; Liquid Crystals; Mouth Mucosa; Nanotechnology; Resveratrol; Surface-Active Agents | 2020 |